<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03128892</url>
  </required_header>
  <id_info>
    <org_study_id>TP18600A-135_197</org_study_id>
    <nct_id>NCT03128892</nct_id>
  </id_info>
  <brief_title>Oxygen Reserve Index Validation for RD Lite Sensors</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Masimo Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Masimo Corporation</source>
  <oversight_info>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Oxygen Reserve Index (ORI) is a parameter that provides information on arterial partial
      pressure of oxygen (PaO2). In this study, the PaO2 is varied by controlling the concentration
      of oxygen the study volunteer breathes. The ORI device measurement is analyzed by comparing
      it to the PaO2 measurements from a laboratory analyzer.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 10, 2016</start_date>
  <completion_date type="Actual">March 29, 2017</completion_date>
  <primary_completion_date type="Actual">March 29, 2017</primary_completion_date>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Specificity of ORI to Detect Drops in Oxygenation</measure>
    <time_frame>1-5 hours per subject</time_frame>
    <description>A measure of the ORI parameter's ability to detect changes in dissolved oxygen levels in blood plasma. Specificity, as measured in this outcome, is the probability of ORI not dropping when there is no drop in blood oxygen levels (desaturation).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sensitivity of ORI to Detect Drops in Oxygenation</measure>
    <time_frame>1-5 hours</time_frame>
    <description>A measure of the ORI parameter's ability to detect changes in dissolved oxygen levels in blood plasma. Sensitivity, as measured in this outcome, is the probability of ORI dropping when there is a drop in blood oxygenation levels (desaturation).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Concordance of ORI to Detect Drops in Oxygenation</measure>
    <time_frame>1-5 hours</time_frame>
    <description>A measure of the ORI parameter's ability to detect changes in dissolved oxygen levels in blood plasma. Concordance, as measured in this outcome, is the probability of ORI to respond accurately to changes (or lack of thereof) in underlying blood oxygenation levels. It is computed as a ratio of true classifications (true positives and true negatives) to the sample size. An ideal detector will have a concordance value of 1 (or 100%).</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Test Subject</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects are enrolled into the test group and all subjects received the Noninvasive Oxygen Reserve Index - RD Lite Sensors</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Oxygen Reserve Index - RD Lite Sensors</intervention_name>
    <arm_group_label>Test Subject</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Competent non-smoking (smokers including e-cigarette users) adults between the ages of
             18 and 50 years of age.

          -  We may also be interested in specifically recruiting smokers for some portions of this
             study as well as non-smokers for other portions of this study.

          -  Must weigh a minimum of 110 lbs and no more than 250 lbs unless subject is over 6 feet
             tall.

          -  BMI less than or equal to 35

          -  Must have a hemoglobin value greater than or equal to 11 g/dL.

          -  Baseline heart rate &gt; 45 bpm and &lt; 85 bpm.

          -  CO value less than or equal to 2.0% FCOHb (unless we are specifically interested in
             recruiting smokers)

          -  Physical status of ASA I or II (American Society of Anesthesiology Class 1; Healthy
             subjects without any systemic disease at all. American Society of Anesthesiology Class
             II; subjects with mild systemic disease)

          -  Blood Pressure (Systolic BP less than for equal to 140 mmHg and Diastolic BP less than
             or equal to 90 mmHg).

          -  Able to read and communicate in English

          -  Has signed written informed consent

          -  Female, non-pregnant.

          -  Female subjects will be provided with a pregnancy test free of charge.

        Exclusion Criteria:

          -  Subjects who do not understand the study and the risks involved.

          -  Subjects with open wounds, lacerations, inflamed tattoos or piercings, visible healing
             wounds.

          -  Subjects with frequent or severe headaches and/or migraine headaches.

          -  Subject has known drug or alcohol abuse. Subjects who uses recreational drugs.

          -  Subject has experienced a head injury with loss of consciousness within the last year.

          -  Any chronic bleeding disorders (i.e. hemophilia)

          -  Any history of a stroke, myocardial infarction, seizures or heart attack.

          -  Any cancer or history of cancer (not including skin cancer).

          -  Chronic neurological diseases (i.e. multiple sclerosis, Huntington's Disease).

          -  Any cardiac dysrhythmias (i.e. atrial fibrillation)(without physicians clearance)

          -  Subject has known neurological and/or psychiatric disorder (i.e. schizophrenia,
             bipolar disorder) that interferes with the subjects' level of consciousness.

          -  Known or concurrent chronic usage of psychoactive or anticonvulsive drugs. Subjects
             with psychiatric conditions or are on psychiatric medications (i.e. tricyclic
             antidepressants, MAO inhibitors, Lithium, neuroleptics, anxiolytics or antipsychotics,
             except SSRIs).

          -  Subject has any medical condition which in the judgment of the investigator and/or
             medical staff, renders them ineligible for participation in this study, such as
             Reynauds Syndrome.

          -  Subject has Wolff-Parkinson-White Syndrome or Stokes-Adams Syndrome

          -  Inability to tolerate sitting still or maintain minimal movement for up to 90 minutes.

          -  For studies involving finger sensors: subjects with polished, gel or acrylic nails,
             skin abnormalities affecting the fingers or arms (such as psoriasis, eczema, angioma,
             scar tissue, burn, fungal infection), distinct finger edema, substantial skin
             breakdown damaged and/or finger nail deformities (specific finger will not be used,
             unless we are specifically testing sensors in use with nail polish, gel, and /or
             acrylic nails).

          -  Subjects who have/are currently taking anticoagulant medication.

          -  Subjects who have had caffeine consumption the day of the study.

          -  Subjects who have taken pain medication within 24 hours of start of study. Unless
             minimal preventative dose recommended for adults (discretion of physician).

          -  Subjects having either signs or history of peripheral ischemia.

          -  Subjects who have had invasive surgery within the past year- including but not limited
             to major dental surgery, gallbladder, heart, appendix, major fracture repairs
             (involving plates/ screws), jaw surgery, Urinary tract surgery, plastic surgery, major
             ENT surgery, joint replacement or gynecological surgeries, heart surgery or thoracic
             surgery.

          -  Subjects who have had minor surgery or conditions in the past two months including but
             not limited to minor foot surgery (bunion), arthroscopic procedure, blood donation,
             plasma donation, skin biopsy/ procedures, root canal, fractures, eye surgery, and
             other minor procedures.

          -  Subjects that have been on antibiotics had congestion, head colds, flu, ear infection,
             chest congestion will have a 2 week waiting period from the time of finishing
             medications and must have no more symptoms.

          -  Subjects with claustrophobia, or anxiety.

          -  Subjects who have been in severe car accidents or a similar type of accidents will
             have a 12 month waiting period, from the time of the accident; unless upon further
             medical history questions the physician determines it does not place the subject in
             any additional harm, increase their risk, or compromise the subjects' safety.

          -  Subjects who have had a concussion will have a 12 month waiting period, from the time
             of the concussion.

          -  Subjects with chronic unresolved asthma, lung disease or respiratory disease.

          -  Subjects with allergies to lidocaine, latex, adhesives, or plastic.

          -  Subjects with heart conditions, Diabetes or hypertension.

          -  Subjects who have given vaginal delivery will have a 6 month waiting period. Subjects
             who had a pregnancy terminated, a miscarriage or had a C-section will have a 12 month
             waiting period.

          -  Subjects who intend on participating in any heavy lifting, repetitive movement of
             their wrist (including riding a motorcycle) or exercise (working out, riding a bike,
             riding a skate board etc.), or any activity that will put additional stress on the
             wrist within 24 hours following a study involving an arterial blood draw and/or
             arterial line placement.

          -  Discretion of investigator/study staff
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Masimo Corporation</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92618</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>April 14, 2017</study_first_submitted>
  <study_first_submitted_qc>April 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2017</study_first_posted>
  <results_first_submitted>June 4, 2020</results_first_submitted>
  <results_first_submitted_qc>July 16, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">July 23, 2020</results_first_posted>
  <disposition_first_submitted>March 15, 2018</disposition_first_submitted>
  <disposition_first_submitted_qc>March 15, 2018</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">July 23, 2020</disposition_first_posted>
  <last_update_submitted>July 16, 2020</last_update_submitted>
  <last_update_submitted_qc>July 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>August 1, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/92/NCT03128892/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 1, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/92/NCT03128892/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Oxygen Reserve Index (ORi) - RD Lite Sensors</title>
          <description>All subjects who are enrolled into the test group and participate in data collection receive the noninvasive Oxygen Reserve Index - RD Lite Sensors.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Oxygen Reserve Index (ORi) - RD Lite Sensors</title>
          <description>All subjects who are enrolled into the test group and participate in data collection receive the noninvasive Oxygen Reserve Index - RD Lite Sensors.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="31"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian or Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Specificity of ORI to Detect Drops in Oxygenation</title>
        <description>A measure of the ORI parameter's ability to detect changes in dissolved oxygen levels in blood plasma. Specificity, as measured in this outcome, is the probability of ORI not dropping when there is no drop in blood oxygen levels (desaturation).</description>
        <time_frame>1-5 hours per subject</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Oxygen Reserve Index (ORi) - RD Lite Sensors</title>
            <description>All subjects who are enrolled into the test group and participate in data collection receive the noninvasive Oxygen Reserve Index - RD Lite Sensors.</description>
          </group>
        </group_list>
        <measure>
          <title>Specificity of ORI to Detect Drops in Oxygenation</title>
          <description>A measure of the ORI parameter's ability to detect changes in dissolved oxygen levels in blood plasma. Specificity, as measured in this outcome, is the probability of ORI not dropping when there is no drop in blood oxygen levels (desaturation).</description>
          <units>percentage of true negative</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PaO2 Threshold: 110 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 120 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 130 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 140 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 150 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 160 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 170 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 180 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 190 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Sensitivity of ORI to Detect Drops in Oxygenation</title>
        <description>A measure of the ORI parameter's ability to detect changes in dissolved oxygen levels in blood plasma. Sensitivity, as measured in this outcome, is the probability of ORI dropping when there is a drop in blood oxygenation levels (desaturation).</description>
        <time_frame>1-5 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Oxygen Reserve Index (ORi) - RD Lite Sensors</title>
            <description>All subjects who are enrolled into the test group and participate in data collection receive the noninvasive Oxygen Reserve Index - RD Lite Sensors.</description>
          </group>
        </group_list>
        <measure>
          <title>Sensitivity of ORI to Detect Drops in Oxygenation</title>
          <description>A measure of the ORI parameter's ability to detect changes in dissolved oxygen levels in blood plasma. Sensitivity, as measured in this outcome, is the probability of ORI dropping when there is a drop in blood oxygenation levels (desaturation).</description>
          <units>percentage of true positives</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PaO2 Threshold: 110 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 120 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 130 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 140 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 150 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 160 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 170 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 180 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 190 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Concordance of ORI to Detect Drops in Oxygenation</title>
        <description>A measure of the ORI parameter's ability to detect changes in dissolved oxygen levels in blood plasma. Concordance, as measured in this outcome, is the probability of ORI to respond accurately to changes (or lack of thereof) in underlying blood oxygenation levels. It is computed as a ratio of true classifications (true positives and true negatives) to the sample size. An ideal detector will have a concordance value of 1 (or 100%).</description>
        <time_frame>1-5 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Oxygen Reserve Index (ORi) - RD Lite Sensors</title>
            <description>All subjects who are enrolled into the test group and participate in data collection receive the noninvasive Oxygen Reserve Index - RD Lite Sensors.</description>
          </group>
        </group_list>
        <measure>
          <title>Concordance of ORI to Detect Drops in Oxygenation</title>
          <description>A measure of the ORI parameter's ability to detect changes in dissolved oxygen levels in blood plasma. Concordance, as measured in this outcome, is the probability of ORI to respond accurately to changes (or lack of thereof) in underlying blood oxygenation levels. It is computed as a ratio of true classifications (true positives and true negatives) to the sample size. An ideal detector will have a concordance value of 1 (or 100%).</description>
          <units>percentage of accuracy</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PaO2 Threshold: 110 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 120 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 130 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 140 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 150 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 160 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 170 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 180 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PaO2 Threshold: 190 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 to 5 hours</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Oxygen Reserve Index (ORi) - RD Lite Sensors</title>
          <description>All subjects who are enrolled into the test group and participate in data collection receive the noninvasive Oxygen Reserve Index - RD Lite Sensors.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Arterial line site sensitivity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Chelsea Frank</name_or_title>
      <organization>Masimo Corporation</organization>
      <phone>949-297-7000</phone>
      <email>studies@masimo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

